Headline News about Bristol-Myers Squibb![]() ![]() ![]() ![]() ![]()
Will Chart Analysts Notice Bad Omen on Bristol-Myers Squibb's Chart
October 10, 2022
Via Benzinga
![]()
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Bristol Myers' Opdivo Combo Treatment Scores European Approval For Skin Cancer Setting
September 19, 2022
Via Benzinga
![]() ![]() ![]() ![]()
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
US Stock Futures Down Ahead Of Fed's Rate Decision This Week, Crude Oil Drops Over 1%
September 19, 2022
Via Benzinga
![]() ![]()
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
Via Benzinga
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|